C57BL/6N-Slc13a5tm1b(EUCOMM)Hmgu/Ieg
Status | Available to order |
EMMA ID | EM:09352 |
International strain name | C57BL/6N-Slc13a5tm1b(EUCOMM)Hmgu/Ieg |
Alternative name | HEPD0667_2_B12 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Slc13a5tm1b(EUCOMM)Hmgu |
Gene/Transgene symbol | Slc13a5 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0667_2_B12. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele (Gt(ROSA)26Sor |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | heterozygous C57BL/6NTac |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Pyridoxine-dependent epilepsy / Orphanet_3006
- Undetermined early-onset epileptic encephalopathy / Orphanet_442835
- Amelocerebrohypohidrotic syndrome / Orphanet_1946
IMPC phenotypes (allele matching)
MGI phenotypes (gene matching)
- abnormal liver morphology / MGI
- abnormal hepatocyte morphology / MGI
- abnormal liver physiology / MGI
- decreased body length / MGI
- decreased body weight / MGI
- hyperactivity / MGI
- abnormal glucose homeostasis / MGI
- abnormal muscle physiology / MGI
- decreased circulating insulin level / MGI
- increased insulin sensitivity / MGI
- no phenotypic analysis / MGI
- decreased susceptibility to age related obesity / MGI
- abnormal glycerol level / MGI
- increased lean body mass / MGI
- increased energy expenditure / MGI
- abnormal metabolism / MGI
- increased oxygen consumption / MGI
- improved glucose tolerance / MGI
- decreased circulating glucose level / MGI
- decreased susceptibility to diet-induced obesity / MGI
- increased carbon dioxide production / MGI
- decreased liver triglyceride level / MGI
- decreased total body fat amount / MGI
- abnormal hepatocyte physiology / MGI
- abnormal susceptibility to weight gain / MGI
- decreased circulating lactate level / MGI
- increased muscle cell glucose uptake / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).